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The saga of the "in 11illO ANA" contin.ues, but now 
with an animal model that might be useful in 
devising studies to further explore the nature of 
this phenomenon. 
K anau chi et 01 (1991) have previously reported the spont~neous. dev~ lopn~ent of lupus erythematosus (LE)-like skin leSIOns 111 MRL/ lpr mice. In an at-tempt to better define the genetic background that predisposes these mice to develop LE-like skin le-
sions, Furukaw a and his colleagues watched for the development of 
skin lesions in aging MRL/ n mice, which lack th e lpr (Fas) gene 
mutation but are 99.6% homozygous with MRL/ lpr mice. The 
resu lts are presented in th is issue (p. 95). 
The authors found that MRL/ n mice spo ntaneously developed 
skin lesions, but at an older age than MRL/ lpr mice. Although the 
histopathology of skin lesions in the aged MRL/ n mice looked less 
lupus- like than in lesions from MRL/ lpr mice, the authors noted 
the frequent occurrence of a homogeneous nuclear ;/1 11;/10 anti-
nuclear antibody (ANA) pattern in skin biopsies from these mice 
that was not noted in the MRL/ lpr mice . At 21 mo of age , 50% of 
MRL/ n mice showed tlus i/l /1 ; /10 ANA in both lesional and 
nonlesiona l skin. Tlus pattern was also found in kidney, Ever, and 
lung cells 6:om affected animals. 
[11 lIi/lO ANAs, including both anti-cytoplasmic and anti-nuclear 
antibodies , have been described in human skin biopsies, primarily 
from patients with connective tissue disorders, most notably LE and 
mixed connective tissue disease (MCTD) (Gilliam, 1975; Shu et 01, 
1977; Izuno, 1978; Prystowsh.-y and T uff.1nelE , 1978; Prystowsh.-y et 
01, 1978; WilEams et 01, 1986; Velthuis et 01, 1990; Burrows et 01, 
1993; Ioannides and Bystryn, 1993 ). It has been estimated to occur 
in approximately 4% of skin biopsies submitted for direct immu-
nofluorescence and has also been found in kidney and lung cell s 
(Williams et aI, 1986). In most cases the patient's ;/1 /1;/10 ANA 
pattem has m atched the ANA pattern produced by their serum in 
indirect immunofluorescence (Williams et 01, 1986). Some investi-
gators have felt that the ill /l i/lo ANA is an artifact tha t a.rises when 
antibodies £i'om blood vessels and interstitial spaces in the biopsy 
specim en ga in access to the epithe lia l ceIJs during tissue processing. 
In an attempt to address this issue, Ioannides and Bystryn raised 
dermis-free epide rmal blister biopsies from fiv e LE patients that had 
i/l vivo ANAs o n skin biopsy. T he b lister tops aU showed intracel-
lular antibodies on direct immunofluorescence. The authors there-
fore argued that the ;/1 lIillo ANA phenomenon is real , because the 
intracellulaJ' antibodies could not have leaked from th e dermis 
during tissu e processing. During the harvesting of blisters, how-
ever, the basa l surface of the blister becomes bathed in fluid that 
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accumulates during the harvesting pe riod, and it is possible that 
antibodies in this fluid produced the intracellular antibodies ob-
served in the bEster tops. 
Since Sontheimer's commentary on the ;/1 /1;110 ANA phenome-
non in Iu s editorial on the work ofIoal1ludes and Bystryn (Sonthei-
m er, 1993), at least three additional studies related to ;/1 11 ; 110 ANAs 
have been published , including the report by Furukawa el 01 in tlus 
issue of the J Ollmal. Burrows et al reported finding 22 cases of 
epidermal nuclear fluorescence during examination by routine 
direct immunofluorescen ce of approximately 2000 patient skin 
biopsies (Burrows et aI, 1993). Over half of tllese cases cam e from 
patients with LE. It is interesting to note that wlule all 22 of these 
cases presented with an ;/1 /1;110 ANA, sera from seven cases were 
ANA-negative by routine indirect immunofluorescence tes ting. 
The authors state that tlus latter finding is evidence that the ;/1 11;/10 
ANA is real, because it would be difficult to attribute the i/l 11;'/0 
ANA to leakage of dermal antibodies in biopsies from patients that 
were ANA-negative. It is unclear £i'om tlus report, however, what 
substrate was used for ANA tes ting. If a substrate other than human 
skin was used , then it is possible that the substrate did not 
sufficiently express the antigen bound by antibodies responsible for 
the ;/1 /1 ; 110 ANA. 
The other more recent study, by Ma et aI, demonstra ted a 
potential m echmusm by which anti-RNP antibodies may gain 
intracellular access to produce the ;/1 11 ; 110 ANA (Ma et ai, 1993). 
They demonstrated that RNP antige ns are expressed on the surface 
ofT lymphocytes, where they can be bound by anti-RNP antibod-
ies. The antibody- antigen complex may then be internalized. 
Similar observations have previously been described for anti-RNP 
antibodies as welJ as for Ro/SS -A, anti-La/SS-B, anti-lustone, 
anti-DNA, and anti-Ku antibodies (LeFeber et 01, 1984; Furukawa 
et 01, 1988; Rieber et 01 , 1989; Furukawa et ai, 1990; Prabhaker et 01, 
1990; Bachmann et aI, 1992; Golan et aI, 1992; Jones, 1992b, 1992a; 
M echerie et aI, 1993). Autoantibodies of many specificities have in 
fact been associated with ;/1 lI i llo ANAs (Williams et 01, 1986; 
Ioannides and Bystryn, 1993) . Furukawa and colleagues provided 
evidence that anti-DNA antibodies may have produced the homo-
geneous nuclear staining in the MRL/ n mice . 
One might wonder why so few LE patients m atufest ;/1 /1 ; 110 
ANAs, because autoantibodies associated with ;/1 lI illO ANAs fre-
quently occur in LE patients. One possibl e explanation for tlus 
observation is that certain LE patients express more of the tar get 
antigens or express m o re antigen on the cell surface of their 
keratinocytes than do other indiv iduals. There have been at leas t 
two studies that support this hypothesis. Golan et 01 demonstrated 
enhanced binding of anti-Sm, RNP, Ro/SS-A, and La/SS-B anti-
bodies in LE-derived keratinocytes after ultraviolet irradiation 
compared to irradiated keratinocytes from norm al controls (Golan 
et 01, 1992) . More recently, Niimi et al reported a 2 ,000-fold 
quantitative difference in keratinocyte expression of tbe Ro/ SS-A 
and La/SS-B antigens among LE patients (Niinu et 01, 1995). 
Further studies are needed to detennine whether these o bserved 
diffe rences in antigen expression in LE keratinocytes determin e 
which patients are more likely to manifest ;/1 11 ; /10 ANAs. 
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If an tibodies truly gain in tracelJular access ill lJ i l/o, one wonders 
w hether these antibodies might then cause cellul ar injury. Do th e 
antibodies detected in the ill Il illO ANA actuall y playa role in the 
pathogenesis of skin lesions that arise in the MRL/n mice and in 
some connective ti ssue disease patients? At leas t three Lines o f 
ev idence argue against this hypothesis. First, MRL/ lpr mice that 
developed spon taneous LE-like skin les ions fa iled to demonstrate 
the i/l. Il illO ANA. Second, the ill 1Ji/10 ANA pattern has also been 
detected in nonlesional MRL/ n skin and in normal skin biopsies 
fi-om patients with variou s cutaneous di sorders (Williams el nl, 
1986; Burrows el nl, 1993; Ioannid es and Bystr yn, 1993). Finally, 
Ioannides and Bystryn reported that in their 22 LE skin biopsies 
with ill Il i/IO AN As, no antibodies were detected in the basal 
keratinocytes, the layer of greatest injury in LE-specific skin disease. 
If th ese antibodies are pathogenic, one would expect to see them at 
the site of injury. Despite these arguments, the nature of the ill viJlo 
ANA phenom enon remains unclear , and the intriguing hypothesis 
that antibodies might gain in tracellul ar access and ca use cellular 
injury deserves further study. 
W e await the final verdict as to w hether the ill Vill O ANA is a real 
or specious phenomenon . lf it is real , then the mechanism by which 
antibodies gain access to intracellular constituents and the role that 
these antibodies migh t play in the path ogenesis of skin disease w ill 
need furth er clarification . T he answers to these qu estio ns may have 
a signifi can t impact on our understanding of the pathogenesis of 
som e autoimmune skin diseases . T he M RL/n murine model of the 
ill Vi/I O ANA identifi ed by Furukawa el nl may be llseful in devising 
studies to further explore the nature of this phenomenon. 
T "is work IIlns sIIpporled ill pnrl by Nnr iolllli illSlill/l eS oIHenll" Grnllls A R 41445 
nlld AR43167. 
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